pestells windfall has me baffled also...when he was hired
pestells windfall has me baffled also...when he was hired and acquired, cytodyn obviously considered his expertise and IP worth an extremely hefty reward. to me it seems outsized as pestell became a massive shareholder, the largest by a mile. but at the time they decided the price was worth it and he would carry this over the HIV finish line with flying colors. and a few short months later it all blew up and the prostate test was useless, and he was eventually fired...so few details released about this drama, we as shareholder deserve more...so how could they have made such a huge blunder?
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Winshear Gold Corp. Engages in Strategic Portsoy Project Agreement VANCOUVER, British Columbia — Winshear Gold Corp. (TSXV: WINS) is thrilled to share news regarding a significant advancement in their mining exploration initiatives. Recently, they formalized an option agreement entailing the Portsoy Project, a sprawling 250 square kilometer area filled with potential...
Continue Reading
Reviving Faith in Education: Examining the Documentary 'Off School Property: Solving the Separation of Church and State' illustrates a pivotal moment for religious instruction. This documentary sheds light on the changing landscape of American education influenced by a little-known Supreme Court ruling. An eye-opening documentary film titled 'Off School Property: Solving...
Continue Reading
Eldorado Gold's Successful Annual and Special Meeting Eldorado Gold Corporation is excited to announce the results from their recent Annual and Special Meeting of Shareholders, where all director nominees received overwhelming support. This meeting heralded a pivotal moment for the company as it continues to gear up for the first production from the transformative...
Continue Reading
BioXcel Therapeutics Shares Experience Significant Growth BioXcel Therapeutics Inc (BTAI) has seen an impressive rise in its stock price recently. As an innovative player in the AI biopharmaceutical domain, the company announced some promising updates that have positively impacted investor sentiment. Positive Feedback from Regulatory Authorities Recently, BioXcel...
Continue Reading
NVIDIA’s Vision for Artificial Intelligence In an engaging interview, NVIDIA Corporation CEO Jensen Huang discussed the company's unwavering focus on supply chain management amid extraordinary demand for their innovative products. The conversation highlighted how significant this demand has been in shaping the recent financial performance of the company. Current Stock...
Continue Reading
